Opinion

Video

Discussing Clinical Trial Enrollment for HER2-Positive Metastatic Breast Cancer With Your Oncologist

Author(s):

Sara M. Tolaney, MD, MPH

Clinical trials should be considered at any point in a patient's journey with HER2-positive metastatic breast cancer, not just when standard options are exhausted, as they provide early access to promising therapies, novel combinations, and cutting-edge care.

Related Videos
Image of woman with blonde hair.
Image of woman with blonde hair.
Image of woman with brown hair.
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
a man and a woman in separate boxes in front of a dark blue background
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Related Content
Image of man with grey hair.
March 18th 2025

The Role of Circulating Tumor DNA in Breast Cancer Monitoring

Dr. Debu Tripathy
Dr. Debu Tripathy discusses recent research on the use of circulating tumor DNA in metastatic breast cancer care.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of woman holding her chest.
March 16th 2025

Why It’s Important to Have Hard Conversations in Breast Cancer Care

Alex Biese
CURE spoke with Kelly Grosklags of Conversations With Kelly at the Miami Breast Cancer Conference.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Illustration of woman with blonde hair.
March 13th 2025

Trusting My Stage 4 Breast Cancer Body

Martha Carlson
Practicing consistency has made a difference for me while living with stage 4 breast cancer.
Image of woman with hand on chest.
March 12th 2025

First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer

Spencer Feldman
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using circulating tumor DNA.